I just received this invitation and thought some of you might be interested or know someone.
Sending all my brothers, sisters and non binary friends a big hug!
I am a researcher at Weill Cornell Medicine and would like to invite you to collaborate with us in our gene therapy trial for APOE4 homozygotes.
Based on our studies over the past 6 years and the epidemiologic data that APOE2 confers benefits and decreases risk of AD, we are initiating a clinical trial using an adeno-associated virus gene transfer vector coding for human APOE2 to treat APOE4 homozygotes. The goal is convert the CNS from APOE4/E4 to APOE2/E4. The trial is an open label, dose-ranging study and will enroll individuals who are APOE4 homozygotes with clinical diagnosis of MCI or AD. The study is listed on clinicaltrials.gov: NCT03634007.
Do you have patients that may benefit from trial participation?
Clinical Research Administrator
Director, Clinical Operations & Regulatory Affairs
Weill Cornell Medicine
Department of Genetic Medicine
1305 York Avenue, 13th Floor | New York, NY 10021
(P) 646.962.5583 | (F) email@example.com